Inventor · disambiguated record
Leonardo R. Allain
Also filed as: ALLAIN LEONARDO · ALLAIN LEONARDO R · ALLAIN LEONARDO RESENDE
9 granted patents·9 pending applications·42 citations·filing 2009–2025
87Inventor score
Files withMERCK SHARP & DOHME9MERCK SHARP & DOHME LLC5MAHJOUR MAJID2ALLERGAN PHARMACEUTICALS INT LTD1MEYER BRIAN K1
Top patents by PatentIndex Score
18 records- 0196US12220408B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Feb 11, 2025·5 cites·30 claims
- 0296US12168004B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Dec 17, 2024·5 cites·30 claims
- 0396US11925709B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2020·Granted Mar 12, 2024·12 cites·10 claims
- 0495US12310953B2Pharmaceutical formulations for the treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted May 27, 2025·3 cites·30 claims
- 0592US10117836B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 6, 2018·15 cites·21 claims
- 0688US2025064788A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 0779US2023248655A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2023·Application pending·0 cites
- 0878US12458633B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·32 claims
- 0978US10603282B2Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudineMERCK SHARP & DOHME·Filed 2016·Granted Mar 31, 2020·2 cites·19 claims
- 1077US12458632B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·29 claims
- 1166US2023248715A1Method of treating acute migraine with cgrp-active compoundMERCK SHARP & DOHME·Filed 2023·Application pending·0 cites
- 1259US2019209478A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1358US10842751B2Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudineMERCK SHARP & DOHME·Filed 2020·Granted Nov 24, 2020·0 cites·11 claims
- 1456US2021330660A1Formulations for cgrp receptor antagonistsMAHJOUR MAJID·Filed 2020·Application pending·0 cites
- 1554US2019070161A1Formulations for cgrp receptor antagonistsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1653US2018092899A1Method of treating acute migraine with cgrp-active compoundMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1749US2016220552A1Formulations for cgrp receptor antagonistsMAHJOUR MAJID·Filed 2014·Application pending·0 cites
- 1846US2010216667A1Method for determining compatibility of an active pharmaceutical ingredient with materialsMEYER BRIAN K·Filed 2009·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →